Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00
Provider: Directors Deals Ltd.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Investor AB to Updates on Sale of Gambro to Baxter International Inc


Wednesday, 17 Jul 2013 08:00pm EDT 

Investor AB announced that the regulatory process to get the Gambro transaction cleared by the authorities is moving along, albeit slower than initially estimated. The transaction is now expected to close during the third quarter of 2013. On December 4, 2012, Investor (49%) and EQT (51%), signed an agreement to divest Gambro to the medical technology company Baxter International Inc. for an agreed total enterprise value of SEK 26.5 billion. According to the agreement, Gambro‚Äôs equity value will be based on the enterprise value after deduction of the net debt at the closing of the transaction. 

Company Quote

246.9
-0.1 -0.04%
11 Jul 2014